Feb 11, 2025 | Benefits Advisory Conference, Benefits management, Caroline Fraker, Compliance, Forensic claims review, MedBen University, No Surprises Act (NSA), Pharmacy, Stop-Loss, Wellness
Over 70 guests from seven states attended the MedBen 2025 Benefits Advisory Conference on January 30. Featuring some of the most respected names in the industry, this invitation-only event provided brokers with an extensive look at the state of benefits...
Feb 10, 2025 | Chronic conditions, Cost Savings, Drug costs, Flexible spending accounts (FSAs), Health care costs, MedBen Rx, Pharmacogenomics, Rx Costs, Savings
Now available through MedBen Rx, pharmacogenomic testing is transforming health care through safer and more effective personalized medicine. Determining how genes affect a person’s response to drugs not only improves patient outcomes, but it also helps control...
Feb 7, 2025 | Employee benefits, High-cost claims, Hospitals, Rx Costs, Survey
In a recent “Pulse of the Purchaser” employer survey, nearly three-quarters (74%) of respondents indicated that rising health care costs might force them to reconsider wage or salary increases. The same percentage also believe that rising costs will compel...
Jan 28, 2025 | Administrative Services Only, Claims, Cost Savings, Discounts, Forensic claims review, Preferred provider organization (PPO), Savings
Many Administrative Services Only (ASO) carriers boast rapid claim turnarounds through auto-adjudication… an emphasis on speed that can result in overpayment. But MedBen forensic claims review prioritizes accountability to ensure that you pay the right price for...
Jan 27, 2025 | Federal Trade Commission (FTC), MedBen Rx, News, Pharmacy Benefits Manager (PBM), Rx Costs, Specialty Drugs, Spread Pricing
Through specialty generic drug markups, three major pharmacy benefit managers (PBMs) earned a collective $7.3 billion above estimated acquisition costs over a five-year period, according to an interim report released by the Federal Trade Commission (FTC)....
